South Rampart Pharma
✓ Verified ManufacturerAbout
South Rampart Pharma is a clinical-stage biopharmaceutical company based in New Orleans, Louisiana, specializing in developing breakthrough non-opioid analgesics for improved pain management. The company focuses on creating innovative pain therapeutics that address critical safety concerns associated with traditional analgesics, including liver toxicity, kidney toxicity, and addiction potential. Their flagship product, SRP-001, represents a significant advancement in pain medication technology as a non-opioid, non-NSAID therapeutic that has successfully completed Phase 1 clinical trials. The compound demonstrated exceptional safety profiles, high tolerability, and robust pharmacokinetics, positioning it for Phase 2 clinical development. South Rampart Pharma has engineered their non-opioid small molecules to specifically bypass the liver and kidney toxicity commonly seen with standard analgesics. Operating from their New Orleans facility, the company addresses the urgent need for safer pain management alternatives in healthcare. Their research and development efforts concentrate on delivering effective analgesic solutions without the dangerous side effects that plague current pain medications. With a strong foundation in pharmaceutical innovation and clinical development, South Rampart Pharma is advancing toward commercialization of their novel pain relief technologies, offering healthcare providers and patients safer alternatives for managing pain conditions.